Noopept (N-Phenylacetyl-L-Prolylglycine)

Noopept is a synthetic neuropeptide that enhances cognitive function through AMPA receptor modulation and increased BDNF expression. This compound improves memory retention by up to 40% through enhanced synaptic plasticity and provides neuroprotective effects against oxidative stress.

Origin & History

Noopept is a synthetic nootropic compound derived from the racetam family. It was developed in Russia in the 1990s as a cognitive enhancer. The compound is synthesized through chemical processes involving the modification of peptide structures.

Historical & Cultural Context

Noopept was developed in Russia and has been used as a cognitive enhancer in Eastern Europe. It is considered a potent alternative to piracetam.

Health Benefits

- Enhances cognitive function and memory retention by facilitating synaptic plasticity, which is crucial for learning. Improved synaptic plasticity can increase memory retention by up to 40%. - Provides neuroprotective effects by reducing oxidative stress, which helps prevent neurodegenerative diseases. Antioxidant properties protect neurons from damage. - Boosts mood and reduces anxiety by modulating serotonin and dopamine levels, promoting emotional balance. Balanced neurotransmitter levels are linked to improved mental health. - Enhances focus and attention by increasing acetylcholine levels, which is vital for cognitive processing. Higher acetylcholine levels support sustained concentration. - Supports brain health by promoting the growth of new neurons, which is essential for cognitive longevity. Neurogenesis is a key factor in maintaining mental agility. - Reduces mental fatigue by improving cerebral blood flow, which ensures adequate oxygen and nutrient supply to the brain. Enhanced blood flow supports prolonged mental activity. - Enhances learning capacity by modulating glutamate receptors, which play a role in synaptic transmission. Efficient glutamate activity is crucial for knowledge acquisition.

How It Works

Noopept acts as a positive allosteric modulator of AMPA receptors, enhancing glutamatergic neurotransmission. It increases brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, promoting neuroplasticity. The compound also modulates acetylcholine and dopamine systems while reducing inflammatory cytokines like TNF-α and IL-1β.

Scientific Research

Several studies, including randomized controlled trials, have shown Noopept's potential in enhancing cognitive function and reducing anxiety. Animal studies support its neuroprotective properties.

Clinical Summary

Human studies on noopept are limited, with most evidence coming from small-scale trials involving 50-200 participants. Russian clinical trials showed improved cognitive performance in elderly subjects with mild cognitive impairment at 10-20mg daily doses. Animal studies demonstrate consistent memory enhancement and neuroprotective effects, but large-scale randomized controlled trials in healthy populations are lacking. Current evidence suggests efficacy but requires more robust clinical validation.

Nutritional Profile

- Contains N-phenylacetyl-L-prolylglycine, a neuropeptide analog.
- Known for its high bioavailability and rapid absorption.
- Exhibits strong antioxidant properties.

Preparation & Dosage

Typical dosage ranges from 10-30 mg per day. Available in powder and capsule forms. Consult a healthcare provider before use.

Synergy & Pairings

Alpha-GPC, Bacopa Monnieri, L-Theanine

Safety & Interactions

Noopept is generally well-tolerated with mild side effects including headaches, irritability, and sleep disturbances at higher doses. It may interact with cholinesterase inhibitors and other nootropics, potentially causing overstimulation. Contraindicated in individuals with seizure disorders due to its excitatory effects on glutamate systems. Safety during pregnancy and lactation is unknown, and use should be avoided in these populations.